MetaCap

Zoar Limited Company Profile

NYSE: ZOARHealthcareDrug Manufacturers - GeneralUSD

3.38-0.98 (-22.48%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Zoar at a glance

Zoar Limited (NYSE: ZOAR) is a Drug Manufacturers - General company in the Healthcare sector headquartered in Hung Hom, Hong Kong. The company's shares have traded publicly since 2026. At a market capitalization of $608.4 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0002078148, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Zoar do?

Zoar Limited, a pharmaceutical company, engages in the development, manufacturing, and distribution of pharmaceutical ingredients (APIs) and intermediates in Africa, the Middle East, India, Central and South America, Asia, and Europe. The company offers APIs for anti-cancer, respiratory diseases, malaria, and cardiovascular health; and orphan drugs for rare diseases. It also provides drug contract development and manufacturing services to pharmaceutical companies. The company was founded in 2012 and is headquartered in Hung Hom, Hong Kong.

Business description based on the company's public filings.

Company information

Legal name
Zoar Limited
Ticker
NYSE: ZOAR
Industry
Drug Manufacturers - General
Headquarters
1504, Peninsula Square, Hung Hom, Hong Kong
Phone
345-749-8307
IPO year
2026
Market cap
$608.40M
SEC CIK
0002078148

Related